Big pharma’s looming threat: a patent cliff of ‘tectonic magnitude’
More than half of physicians admit to changing perceptions of a drug due to social media
Pfizer's maternal RSV vaccine filing gets priority review
Medivir completes initial Phase Ib part of HCC therapy trial
*please scroll down for all the latest news*
